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Abstract
Kell, a 93 kDa type II membrane glycoprotein, and XK, a 444 amino acid multi-pass membrane protein, are blood group
proteins that exist as a disulfide-bonded complex on human red cells. The mechanism of Kell/XK assembly was studied in
transfected COS cells co-expressing Kell and XK proteins. Time course studies combined with endonuclease-H treatment
and cell fractionation showed that Kell and XK are assembled in the endoplasmic reticulum. At later times the Kell
component of the complex was not cleaved by endonuclease-H, indicating N-linked oligosaccharide processing and transport
of the complex to a Golgi and/or a post-Golgi cell fraction. Surface-labeling of transfected COS cells, expressing both Kell
and XK, demonstrated that the Kell/XK complex travels to the plasma membrane. XK expressed in the absence of Kell was
also transported to the cell surface indicating that linkage of Kell and XK is not obligatory for cell surface
expression. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Kell is a 93 kDa type II membrane glycoprotein [1]
and XK a 444 amino acid integral membrane protein
that is predicted to span the membrane 10 times [2].
Both Kell and XK proteins display blood group anti-
gens and on human red cell membranes Kell and XK
are linked by a disul¢de bond [3,4]. Kell is highly
polymorphic, and over 20 di¡erent antigens are rec-
ognized as part of the Kell blood group system.
Some of the Kell antigens are strong immunogens
and the Kell blood group system is important in
transfusion medicine since Kell antibodies can elicit
severe reactions if incompatible blood is transfused
[5,6]. Kell antibodies can also suppress erythropoiesis
and cause anemic disease in newborn infants [7^9].
The di¡erent Kell antigens are due to point muta-
tions in KEL leading to single amino acid changes in
the extracellular domain of the glycoprotein [10^15].
XK on the other hand, carries a single blood group
antigen, termed Kx, which is present in all red cells
except in the rare McLeod phenotype. McLeod red
cells have aberrant shape, appearing as acanthocytes,
and together with lack of XK there is a marked
diminution of Kell protein and all Kell antigens are
markedly weakened. Lack of XK is associated with
disease and most McLeods exhibit a late onset form
of muscular dystrophy, cardiomyopathy, and nerve
degeneration [5,6,16,17].
Expression of wild-type and mutant recombinant
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Kell and XK proteins has indicated that Kell Cys72,
which is close to the membrane spanning domain, is
linked to XK Cys347 located in a small ‘loop’ which
contributes the ¢fth extracellular XK domain [18].
Although Kell and XK exist on red cell membranes
as a disul¢de-bonded complex, association of the two
proteins is not needed for presentation of Kell blood
group antigens. Expression of Kell protein in a vari-
ety of transfected cells indicates that Kell can be
transported to the plasma membrane without co-ex-
pression of XK and the recombinant protein ex-
presses Kell surface antigens [15,19]. Likewise, Kx
antigen is present in Ko (null) red cell membranes
which have little, or no, Kell protein [5,6]. It is not
known, however, whether the association of Kell and
XK is needed for red cell functions, since the com-
plete physiological roles of the two proteins remain
to be determined. Kell protein has close structural
and sequence homology to the M13 or neprilysin
sub-family of zinc endopeptidases [15] which include
neutral endopeptidase 24.1 (NEP), endothelin con-
verting enzyme (ECE) and the product of the PEX
gene [20^24]. The members of the M13 family of
membrane zinc endopeptidases are involved in the
activation and inactivation of biologically active pep-
tide hormones. Recently we determined that the ex-
tracellular domain of Kell protein, like ECE-1, acti-
vates the endothelins, but that unlike ECE-1 Kell
preferentially activates endothelin-3 rather than en-
dothelin-1 [25]. Although absence of XK is associ-
ated with red cell acanthocytosis and with muscle
and nerve disorders and its primary structure has
features that suggest that it may be a membrane
transporter [2], its function remains to be deter-
mined.
To study the mechanism of Kell/XK assembly we
have, using co-expression of Kell and XK in COS
cells, determined the biosynthesis, site of assembly
and intracellular transport of Kell and XK proteins.
2. Materials and methods
2.1. Antibodies
A 42-mer synthetic peptide, corresponding to the
predicted second extracellular loop of XK was pre-
pared by Synpep, Deblin, CA, USA and a 30-mer
peptide representing the N-terminal domain of Kell
protein (amino acids 2 to 31) was synthesized by the
Microchemistry Laboratory of the New York Blood
Center. Polyclonal antibodies were produced in rab-
bits by injection of the synthetic peptides mixed with
Freunds adjuvant and the antisera were a⁄nity pu-
ri¢ed.
2.2. Construction of expression vectors
XK cDNA was a generous gift from Drs. M. Ho
and A.P. Monaco, Imperial Cancer Research Fund
Laboratories, Institute of Molecular Medicine, John
Radcli¡e Hospital, Oxford, England. Two pRC/
CMV expression vectors were constructed. One vec-
tor contained only XK cDNA and the other had
both XK and Kell cDNAs. For the vector containing
only XK, the cDNA was placed in pRc/CMV (Invi-
trogen, Inc.) in HindIII and XbaI cloning sites. For
the vector containing both XK and Kell, the Kell
cDNA was modi¢ed to contain a Kozak sequence
(GCCGCCACC) [26] before the ATG initiation co-
don. The modi¢ed Kell cDNA and XK cDNA were
placed in tandem, each with its own CMV promoter
and adenylation signal, into pRc/CMV as previously
described.
2.3. Transient transfection of COS cells
COS-1 cells (ATCC CRL 1650) were transfected
by electroporation using a Gibco Cell Porator with
an electrical pulse of 250 V and 330 WF. About
2U107 cells were suspended for 15 min in 1 ml of
Dulbecco’s phosphate-bu¡ered saline with 10 Wg of
plasmid DNA prior to electroporation. The cells
were allowed to recover in ice for 10 min and were
seeded at about 5U106 cells on 100 mm plastic Petri
dishes (Falcon, Becton Dickinson, Franklin Lakes,
NJ, USA). The cells were cultured in 10 ml of
RPMI 1640 medium supplemented with 10% fetal
bovine serum and grown to con£uence, usually in
2 days.
2.4. Metabolic labeling of transfected COS cells with
L-[35S]methionine
Con£uent COS-1 cells were washed with phos-
phate-bu¡ered saline and incubated at 37‡C for 30
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min in 1 ml of L-methionine-free Dulbecco’s minimal
essential medium (Life Technologies, Inc.) containing
0.5 mCi of L-[35S]methionine (NEN Research Prod-
ucts, Boston, MA, USA, speci¢c activity 1110 Ci/
mmol). The cells were then washed twice with phos-
phate-bu¡ered saline and incubated with growth me-
dium for various periods of time.
2.5. Cell fractionation
About 108 transfected COS cells were lysed with
2 ml of ice-cold water for 5 min and the cells further
disrupted with a loose-¢tting Dounce homogenizer.
The cell suspension was adjusted to 0.25 M sucrose
and centrifuged at 500Ug for 10 min to remove un-
broken cells, debris and a nuclear fraction. The
supernatant fraction was adjusted to 1.38 M sucrose
and overlaid over 2 M sucrose. A discontinuous su-
crose gradient of 1.1 M, 0.6 M and 0.25 M sucrose
was then applied and centrifuged in a Beckman SW
40.1 rotor at 105 000Ug for at least 3 h. A rough ER
fraction sediments at the 2 M and 1.38 M interface, a
smooth ER fraction at the 1.38 M and 1.1 M inter-
face and a Golgi cell fraction at 1.1 M and 0.6 M
sucrose [27,28]. The purity of the cell fractions was
monitored by electron microscopy (data not shown).
2.6. Surface-labeling of COS cells
Transfected COS cells were surface-labeled with
125I by the lactoperoxidase method [29]. Con£uent
COS cells, attached to 100 mm Petri dishes, were
radiolabeled, washed with phosphate-bu¡ered saline
to remove free iodine and solubilized with detergents
prior to isolation of XK and Kell/XK complex by
immunoprecipitation.
2.7. Immunoprecipitation of Kell/XK complex
COS cells were lysed with 0.5% sodium deoxycho-
late and 1% dodecyl-L-D-maltoside (Sigma, St. Louis,
MO, USA). Included in the lysing solution were the
following protease inhibitors: 0.1 mM TPCK, 0.1
mM PMSF and 10 units/ml of aprotinin (Sigma
Chem. Co., St. Louis, MO, USA). The lysate was
cleared by centrifugation in a microfuge at 12 000
rpm for 10 min at 4‡C. Antibodies, to a peptide
representing the second loop of XK or to a peptide
from the cytoplasmic domain of Kell, were added
and incubated overnight at 4‡C. The immune com-
plex was isolated with protein A-Sepharose, the pro-
teins eluted with SDS bu¡er (0.125 M Tris-HCl, pH
6.8, 1% SDS, 5% glycerol) containing 4 M urea and
separated on 9% polyacrylamide gels [18,30] or pre-
casted 4^12% Tris-glycine gradient gels (Novex, San-
diego, CA, USA).
The immune complex was treated with endonu-
clease-H (New England BioLabs Inc., Beverley,
MA, USA) to remove the high mannose chitobiose
core from glycoproteins [31] as recommended by the
manufacturer. The control samples that were not
treated with endonuclease-H underwent the same
procedure except that the enzyme was not added.
2.8. Two-dimensional gel electrophoresis
In the ¢rst dimension, radioactive proteins present
in the immunoprecipitate obtained with antibody to
XK were separated by SDS-PAGE on a 4^12% Tris-
glycine gel (Novex). In the second dimension, an
appropriate lane was excised from the gel, soaked
in SDS bu¡er containing 5% 2-mercaptoethanol for
30 min and loaded on top of another precasted
4^12% Tris-glycine gel (Novex).
3. Results
3.1. Time course of Kell/XK assembly
COS cells expressing both Kell and XK proteins
were ‘pulse’-labeled for 10 or 30 min with L-
[35S]methionine. The cells that were pulse-labeled
for 10 min were ‘chase’ incubated for 10, 20, 30, 40
and 50 min and those labeled for 30 min were
‘chased’ for 1, 2, 3, and 5 h. Radioactive Kell/XK
complex was isolated by immunoprecipitation with
antibody to XK, the radioactive proteins separated
on non-reduced SDS-PAGE, detected by autoradiog-
raphy and quantitated by densitometry.
At the end of 10 min pulse-labeling with L-
[35S]methionine, a prominent radioactive protein
was detected with an apparent molecular weight of
38 kDa, the location at which XK migrates (Fig. 1A,
lane 1). Another radioactive protein migrating near
the top of the gel was also present. The high molec-
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ular weight protein is also isolated from control COS
cells not expressing Kell or XK, suggesting that it is
a contaminant co-precipitating during the procedure
(data not shown). Although not easily detected at 10
and 20 min, radioactivity was increasingly incorpo-
rated into the Kell/XK complex that migrates at 130
kDa during the ¢rst 50 min (Fig. 1A). The Kell/XK
radioactive complex was not easily apparent until 30
min chase (panel A, lane 4), but densitometry meas-
urements detected increments of incorporation at the
earlier times.
The relative radioactivities in free XK and in the
Kell/XK complex were quantitated by densitometry
and are presented in Fig. 1C. Results from two ex-
periments are shown. In one set COS cells were
‘pulsed’ for 10 min and ‘chased’ at 10 min time in-
tervals up to 50 min (Fig. 1A) and in the other set
the cells were ‘pulsed’ for 30 min and ‘chased’ for 1 to
5 h (Fig. 1B). In the cells pulsed for 10 min there
was a linear increase of incorporation of radioactiv-
ity into the Kell/XK complex and a concomitant
decrease in radioactive ‘free’ XK. In cells ‘pulsed’
for 30 min and chased for 1 to 5 h the radioactivity
in the Kell/XK complex is near maximal at 1 h of the
‘chase’ period and there is a slight gradual increase
for up to 5 h. Even after 5 h of chase nearly 70% of
the radioactivity remained as free XK (Fig. 1B and
C).
3.2. Two-dimensional SDS-PAGE analysis of Kell/XK
complex
COS cells expressing both Kell and XK were met-
abolically labeled with L-[35S]methionine for 30 min,Fig. 1. Time course of Kell/XK assembly. COS cells co-express-
ing Kell and XK were ‘pulse’-labeled either for 10 min and
chase incubated at 10 min intervals up to 50 min (panel A) or
pulse-labeled for 30 min and chase incubated up to 5 h (panel
B). Radioactivity was quantitated from autoradiograms by den-
sitometry and the relative densities, as a percentage of free XK
versus Kell/XK complex, at each time point, are graphically
presented in panel C. The solid triangles and dots are from
panel A and the open triangles and dots from panel B. Panel
A: lane 1, 10 min pulse and zero chase; lane 2, 10 min chase;
lane 3, 20 min chase; lane 4, 30 min chase; lane 5, 40 min
chase; and lane 6, 50 min chase. Panel B: lane 7, 30 min pulse
and 1 h chase; lane 8, 2 h chase; lane 9, 3 h chase; and lane
10, 5 h chase.
Fig. 2. Two-dimensional SDS-PAGE of Kell/XK complex. COS
cells co-expressing Kell and XK were metabolically labeled for
10 min and chase incubated for 3 h. Isolated proteins were ¢rst
separated under non-reducing conditions (¢rst dimension) then
under reducing conditions (second dimension). The locations at
which Kell and XK migrate are marked.
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‘chase’ incubated for 3 h and XK and its associated
proteins isolated by immunoprecipitation with anti-
body to XK. The radioactive proteins isolated were
analyzed by two-dimensional SDS-PAGE, autora-
diography and densitometry. The ¢rst dimension
was in non-reducing conditions and the second di-
mension in reducing conditions (Fig. 2). On the ¢rst
dimension free XK and the Kell/XK complex con-
tained the majority of radioactivity with less
amounts in two other proteins with apparent molec-
ular weights of about 60 and 70 kDa. The 60 and 70
kDa proteins appeared more prominent in the sec-
ond dimension than in the ¢rst dimension.
In the second dimension free XK again migrated
as a 38 kDa protein, with noticeable trailing of pro-
tein radioactivity. The 130 kDa Kell/XK complex, on
second dimension, was separated into several radio-
active components. The majority of the radioactivity
was in Kell (93 kDa) with less amount at 38 kDa,
representing free XK. In addition, signi¢cant
amounts of radioactivity trailed above Kell protein.
The relative radioactivity of Kell and XK compo-
nents in the complex was determined by densitome-
try and the values corrected to re£ect the methionine
contents of these two proteins. Kell has 18 methio-
nine residues and XK has nine. A Kell/XK ratio of
1.34 was obtained.
3.3. Kell is associated with XK in the endoplasmic
reticulum
COS cells expressing both XK and Kell were la-
beled for 1 h with L-[35S]methionine and some were
‘chase’ incubated for 5 h. The cells labeled for 1 h
were fractionated into rough and smooth endoplas-
mic reticulum cell fractions. A Golgi cell fraction was
obtained from cells ‘chased’ for 5 h. Kell/XK com-
plex was isolated from each of the fractions with
antibody to XK, treated with endonuclease-H and
separated by SDS-PAGE in reducing conditions
(Fig. 3). Endonuclease-H removes N-linked man-
nose-rich oligosaccharides from glycoproteins [31]
present in the endoplasmic reticulum (ER) and
does not cleave oligosaccharides from glycoproteins
whose N-linked sugars have been further processed
in the Golgi cell fractions [32]. Kell, but not XK, is a
glycoprotein, and therefore endonuclease-H treat-
ment provides information on oligosaccharide proc-
essing and cellular location of the Kell component of
the Kell/XK complex.
In both the rough and smooth endoplasmic retic-
ulum fractions, antibody to XK co-isolated radioac-
tive Kell protein. The Kell component of the Kell/
XK complex was cleaved by endonuclease-H, migrat-
ing faster on SDS-PAGE, and indicating that, as
expected from an N-linked glycoprotein present in
the ER, Kell, at this stage, contains high mannose
sugars (Fig. 3, lanes 1^4).
A Kell/XK complex, evidenced by the co-isolation
of Kell with antibody to XK, was also obtained from
the Golgi cell fraction, measured after 5 h of chase
incubation. As compared to Kell present in the ER
fractions, the Kell component in the Golgi was en-
donuclease-H insensitive, indicating processing of its
N-linked sugars (Fig. 3, lanes 5 and 6).
These results demonstrate that Kell/XK linkage
commences in the ER and then proceeds to the Golgi
cell fraction.
3.4. Endonuclease-H insensitivity of Kell from red cell
membranes
Kell, expressed in COS cells, migrates slightly fast-
er on SDS-PAGE when treated with endonuclease-
H, even after it has entered the Golgi compartment
(Fig. 3, lanes 5 and 6). The slight sensitivity of Kell
to endonuclease-H at times when oligosaccharide
processing has occurred may be due to several rea-
sons. It could be due to aberrant N-glycosylation of
Fig. 3. Kell/XK complex in the endoplasmic reticulum and Gol-
gi cell fractions. COS cells co-expressing Kell and XK were
metabolically labeled for 1 h and chase incubated for 5 h.
Rough and smooth ER fractions were obtained at 1 h of incu-
bation and Golgi cell fractions at the 5 h chase period. Kell/
XK complex was isolated with antibody to XK, treated with
endonuclease-H and separated on reduced SDS-PAGE. Lanes 1
and 2 are from rough ER samples; lanes 3 and 4 from smooth
ER; and lanes 5 and 6 from Golgi cell fractions. Lanes 1, 3
and 5 were untreated and lanes 2, 4 and 6 were treated with
endonuclease-H.
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Kell by COS cells, to a proteolytic contaminant in
the endonuclease-H or could be a normal feature of
Kell glycoproteins. To distinguish between these pos-
sibilities, Kell protein, isolated from normal human
red cells, was treated with endonuclease-H, separated
by reduced SDS-PAGE and identi¢ed by Western
immunoblotting (Fig. 4). Endonuclease-H treatment
did not a¡ect the electrophoretic mobility of Kell
isolated from red cells, indicating that the endonu-
clease-H did not contain proteolytic enzymes and
that the electrophoretic mobility of Kell from red
cells is not a¡ected by endonuclease-H. Therefore
these results suggest that recombinant Kell, ex-
pressed by COS cells, may have di¡erent N-linked
sugars than Kell present in red cells and this results
in a slightly faster electrophoretic migration on treat-
ment with endonuclease-H.
3.5. XK can be transported to the cell surface in the
absence of Kell
Previous studies in which Kell was expressed in
transfected cells demonstrated that Kell protein trav-
els to the cell surface and expresses Kell blood group
antigens [15,19]. To determine whether XK can also
be transported to the cell surface in the absence of
Kell, COS cells expressing only XK, or both Kell
and XK, were surface-labeled by the lactoperoxidase
method with radioactive iodine. The washed cells
Fig. 5. Kell and XK are surface-exposed. COS cells expressing
XK alone or both Kell and XK were surface-labeled with 125I
by the lactoperoxidase-catalyzed method. The cells were lysed
and XK, or Kell/XK complexes, isolated with antibody to XK.
Proteins were separated by reduced SDS-PAGE and detected
by autoradiography. Lane 1 shows total surface-labeled proteins
from COS cells expressing only XK and lane 2 total surface-la-
beled proteins from cells co-expressing Kell and XK. Lanes 3
and 4 show surface-exposed proteins that were immunoprecipi-
tated with antibody to XK. Lane 3 shows radioactive proteins
from cells only expressing XK and lane 4 from cells co-express-
ing both Kell and XK. The locations at which Kell and XK
migrate are marked.
Fig. 4. Kell from human red cells is not cleaved by endonu-
clease-H. Kell protein, isolated from red cells, was treated with
endonuclease-H separated by reduced SDS-PAGE and detected
by Western immunoblotting using antibody to Kell. Lane 1
contains the untreated sample and lane 2 the endonuclease-H-
treated sample.
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were lysed with detergent and XK isolated with anti-
body to XK. Separation of the total cellular proteins
on reduced SDS-PAGE, from both the COS cells
expressing only XK, or expressing both Kell and
XK, showed a simple pattern of radioactive proteins
indicating that, as expected from the lactoperoxidase
method, only surface-exposed proteins were labeled
(Fig. 5, lanes 1 and 2). There was little, or no, di¡er-
ence in the pattern from cells expressing only XK or
expressing both Kell and XK indicating that Kell
and XK represent a minor fraction of surface-ex-
posed protein. Antibody to XK, however, isolated
surface-iodinated XK from COS cells expressing
only XK demonstrating that XK is present on the
cell surface (Fig. 5, lane 3). In COS cells co-express-
ing both Kell and XK, antibody to XK isolated both
radioactive XK and Kell indicating that the complex
was also present on the cell surface (Fig. 5, lane 4).
Less XK was placed on the cell surface when both
Kell and XK were co-expressed than when XK was
expressed by itself (Fig. 5, lanes 3 and 4).
4. Discussion
Both Kell and XK are integral membrane proteins
that are partially exposed on the red cell surface.
Their structures are very di¡erent; Kell is a glyco-
protein that spans the membrane once [1] and XK is
not glycosylated and traverses the membrane 10
times with both the N- and C-termini in the cyto-
plasm [2]. On red cells, Kell and XK are linked by an
extracellular disul¢de bond [3,4] connected by Kell
Cys72 and XK Cys347 [18]. Our studies demonstrate
that in transfected COS cells, Kell and XK are ¢rst
linked in the ER and are transported, via the normal
secretory pathway, to the Golgi and the plasma
membrane.
Previous studies established that Kell and XK
form a disul¢de-linked complex that migrates on
SDS-PAGE with an apparent molecular weight of
approximately 130 kDa. The two proteins are linked
by a single disul¢de bond between Kell Cys72 and
XK Cys347, since substitution of these cysteine resi-
dues with serine abolished the formation of the 130
kDa Kell/XK complex [18]. In the present studies we
con¢rm, using antibody to XK rather than antibody
to Kell and by two-dimensional SDS-PAGE analysis,
that Kell and XK are the major components of the
130 kDa complex. The molar ratios of Kell and XK,
as determined by densitometry and correction of the
radioactive values to re£ect di¡erent methionine con-
tent, indicate a Kell/XK ratio of 1.34. The lower
amount of XK may be due to a lower recovery of
XK from the complex due to aggregation. XK is a
very hydrophobic protein that often migrates on
SDS-PAGE, even in reducing conditions, as an ag-
gregate. As noted in Fig. 2, the XK that migrated as
‘free’ XK on the ¢rst dimension produced some trail-
ing or streak in the second dimension. The XK com-
ponent of the Kell/XK complex behaves similarly
and the aggregated form is not measured, leading
to low recoveries. Aggregation of XK has also been
described by others [4].
The environment of the ER encourages protein
assembly and disul¢de linkages, since it maintains
an oxidative redox potential, contains protein disul-
¢de isomerase which catalyzes disul¢de formation,
and also has other resident chaperone proteins that
facilitate folding and assembly of protein complexes
[33^35]. As noted in Fig. 1, after a 10 min ‘pulse’
incubation some complex formation was measured
10 min into the ‘chase’ period and the disul¢de link-
age of Kell and XK proceeds linearly for about an
hour. Multi-component membrane complexes, such
as the T cell antigen receptor, which is composed
of at least seven polypeptides, some of which are
disul¢de-linked, show di¡erent rates of assembly
for their component parts. Similarly to the assembly
of Kell and XK the disul¢de linkage of K and L
component polypeptides of T cell antigen receptor
also occurs slowly, with an estimated half time of
10 to 30 min [36,37].
Two lines of evidence show that Kell and XK are
disul¢de-linked in the ER. The ¢rst and most direct
evidence is that cell fractionation studies showed that
the Kell/XK complex was present in both the rough
and the smooth ER cell fractions. Secondly, the Kell
component of Kell/XK was cleaved by endonuclease-
H, con¢rming a pre-Golgi cellular location (Fig. 3).
Kell can travel to the cell surface and appears to
be properly folded in the absence of XK. Previous
studies showed that, in the absence of XK, Kell is
surface-expressed and acquires a tertiary structure
that resembles the native protein, since it exhibits
conformational antigenic epitopes [15,19]. In this
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study we demonstrate that XK can also be trans-
ported to the cell surface in the absence of Kell
and that when co-expressed both Kell and XK exist
as a disul¢de-bonded complex on the plasma mem-
brane (Fig. 5).
The recombinant expression of Kell and XK by
COS cells does not completely mirror the in vivo
situation. Two rare red cell phenotypes, involving
Kell and XK, suggest that co-expression of Kell
and XK is necessary for optimal expression of both
proteins on the cell surface. In the McLeod pheno-
type, red cells lack XK and there is an accompanying
marked decrease in the amount of Kell present on
the membrane. In the Ko (null) phenotype the red
cells have no detectable Kell protein and have de-
creased amounts of XK protein, although as meas-
ured by serological procedures the Ko (null) red cells
have enhanced amounts of an antigen, Kx, that is
carried on XK protein. In the recombinant system,
co-expression of Kell and XK does not enhance the
amount of Kell or XK that is placed on the cell
surface.
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